Skip to Page Content
Delaware.gov  |  Text OnlyGovernor | General Assembly | Courts | Elected Officials | State Agencies
 Photo: Featured Delaware Photo
 
 
 Phone Numbers Mobile Help Size Print Email

Delaware General AssemblyDelaware RegulationsAdministrative CodeTitle 16Department of Health and Social ServicesDivision of Public HealthFamily Health Services

Table of Contents Previous Next

Authenticated PDF Version

 

 

1.0 Purpose

1.1 Birth defects are one of the causes of infant mortality and disabilities in Delaware. A Birth Defects Surveillance System, or Birth Defects Registry, will enable the Department of Health and Social Services (DHSS), Division of Public Health (DPH) to collect birth defects data, to create a statewide registry, and to link surveillance with tracking of individual children for the provision of services.

1.2 The purpose of the Birth Defects Registry is to provide information to Public Health officials as to the existence of previously unrecognized health and environmental hazards, help prevent certain birth defects and ultimately decrease the infant mortality rate. The Birth Defects Registry will gather data to assist with identification of risk factors, including environmental and hereditary, assist in the investigation of causes and prevalence; assist in the development of strategies to reduce the occurrence of, or prevent such defects; and track and follow-up abnormal newborn hearing screening results.

1.3 The usefulness of the data collected in the Birth Defects Registry will depend upon the full and accurate reporting of such defects by health care practitioners, health care facilities, clinics and laboratories.

1.4 The Birth Defects Registry will be a component of the Newborn Screening Case Management System, including metabolic and hearing screening. All results of metabolic and hearing screens will become part of the screening record. Tracking and follow-up of incomplete and abnormal cases will be followed by the Division of Public Health Newborn Screening Program.

 

2.0 Definitions

The following words shall have the meanings indicated:

"Birth Defect" means any structural or biochemical abnormality, regardless of cause, diagnosed at any time before or after birth, that requires medical or surgical intervention or that interferes with normal growth or development. This includes abnormal newborn hearing screening. Reportable birth defects are listed in Appendix A of these Regulations.

"Division" refers to the Division of Public Health under the Department of Health and Social Services.

"Registry" means a central data bank containing collected, classified, coded, and sorted data relating to defects in children under age 5, reported by health care providers.

"Surveillance" means the process of identifying and investigating birth defects in children under age 5.

 

3.0 Reporting Requirements

The provisions of this section shall apply to the Delaware Health and Social Services, Division of Public Health, Birth Defect Registry:

3.1 The registry shall collect information on any birth defect diagnosed in utero and postpartum on anyone who is a resident of the state of Delaware, or whose parent is a resident of Delaware, and who is diagnosed at any time prior to age five (5) as having a birth defect. For the purposes related to the registry the Division shall have access to any medical record of the child that pertains to a diagnosed or suspected birth defect. Prenatal information on the birth mother may be obtained with prior consent.

3.2 Any diagnosed birth defects shall be reported for all infants and children up to age 5, including those who have since died (if the data is still available).

3.3 For purposes of these reporting requirements, reportable diagnoses are those diagnoses, from the International Classification of Diseases (ICD), as listed in Appendix A of these regulations. The reportable diagnoses listed in Appendix A may be revised, upon notice, to reflect changes in publications accepted for use by the Centers for Disease Control and Prevention or State.

3.4 The following persons and organizations are required to report occurrences of birth defects within 30 days of diagnosis to the Division of Public Health.

3.4.1 Any physician, surgeon, dentist, podiatrist, certified nurse midwife, or other health care practitioner who diagnoses or provides treatment, or both, for a child under age 5 with birth defects who is not known to be previously reported;

3.4.2 The designated representative of any clinical laboratory that performs any test which identifies a child or children under age 5 with birth defects not known to be previously reported; and

3.4.3 The designated representative of any hospital, dispensary, clinic, or other similar public or private institution that diagnoses or provides treatment, or both, for a child or children under age 5 with birth defects who is not known to be previously reported.

3.4.4 This section of the regulations shall not apply to any person or private institution that, as an exercise of religious freedom, treats the sick or suffering by spiritual means through prayer alone.

3.5 The administrative officer of every health care facility shall be responsible for establishing reporting procedures at that facility, using the identified Birth Defect Registry reporting form. Reporting procedures must ensure that each infant initially diagnosed as having a birth defect shall be reported to the Division. Any presumptive or actual diagnosis in a child up to the age of 5 must be reported to the Division.

3.6 Reporting sources shall complete the Division of Public Health Birth Defects Surveillance Form for each reported case, and forward the completed form to the Division of Public Health Director or designee.

3.7 Reporting sources are required to submit annual follow-up information as requested through Birth Defect Program.

 

4.0 Confidentiality of Reports

4.1 No report of a diagnosis or treatment of a birth defect shall be disclosed in such a way as to identify the child who is the subject of the report, or as to identify the child's family. However, patient-identifying information may be exchanged among authorized agencies as approved by the Department and upon receipt by the Department of satisfactory assurances by those agencies of the preservation of the confidentiality of such information. Agencies will maintain the confidentiality of any information exchanged for the purpose of delivery of program services, evaluation, early intervention and epidemiological investigation.

4.2 Any parent, custodian or guardian of any infant having any birth defect may refuse disclosure to the surveillance system and registry of the infant’s name and identifying information on the grounds that such birth defect identification is contrary to the religious tenets and practices of the infant’s parent, custodian or guardian.

4.3 No individual or organization providing information pursuant to these regulations shall be held liable for divulging such information to the Division.

 

5.0 Penalties

Any person or organization required to report the diagnosis or treatment of a birth defect pursuant to these regulations, and who violates these regulations, shall be subject to a fine of up to $100 for each violation, pursuant to 16 Del.C. Sec. 206. Justices of the Peace Courts have jurisdiction over such violations.

 

6.0 Severability

In the event any particular clause or section of the regulations should be declared invalid or unconstitutional by any court of competent jurisdiction, the remaining portions shall remain in full force and effective.

 

Table 1: APPENDIX A October 2002

Broad Categories

Specific Categories

ICD-9 Codes

Congenital Infections

 

 

 

Congenital syphilis

090.0 - 090.3

 

Congenital rubella

771.0

 

Congenital cytomegalovirus

771.1

 

Congenital toxoplasmosis (not specific code)

771.2

Other infections specific to perinatal period

 

771.80

 

Other congenital infections

771.x

Neoplasms

Neurofibromatosis

237.70

Endocrine, Nutritional, Metabolic, Immunological Diseases

 

 

 

Congenital hypothyroidism

243.00

 

Phenylketonuria

270.10

 

Galactosemia

271.1

 

Cystic Fibrosis

277.00.01

 

Other Metabolic diseases

 

Diseases of Blood

 

 

 

Sickle Cell Disease

282.60

 

Other hemoglobinopathies

282.63, 282.69, 282.4

Developmental Disorders

 

 

 

Developmental Language Disorder

315.31-315.39

 

Coordination Disorder

315.40

 

Mental Retardation

317 - 319

Congenital Anomalies of Central Nervous System

 

 

 

Anencephalus

740.0 -740.1

 

Spina bifida without anencephalus

741.0,741.9 w/o

740.0-740.10

 

Hydrocephalus without spina bifida

742.3 w/o

741.0, 741.9

 

Encephalocele

742.0

 

Microcephalus

742.1

 

Holoprosencephaly/Porencephaly

742.2

 

Other Congenital Anomalies of Nervous System

742.4 - 742.9

Congenital Anomalies of the Eye

 

 

 

Anophthalmia/microphthalmia

743.0,743.1

 

Congenital cataract

743.30 -743.34

 

Aniridia

743.45

 

Glaucoma

743.20 -743.22

 

Coloboma

743.46*

Congenital Anomalies of the Ear

 

 

 

Anotia/microtia

744.01,744.23

Congenital Anomalies of the Cardiovascular System

 

 

 

Common truncus

745.0

 

Transposition of great arteries

745.10,745.11, 745.12, 745.19

 

Tetralogy of Fallot

745.2

 

Ventricular septal defect

745.4

 

Atrial Septal Defect

745.5

 

Endocardial cushion defect

745.60,745.61, 745.69

 

Single Ventricle

745.3

 

Pulmonary valve atresia and stenosis

746.01,746.02

 

Tricuspid valve atresia and stenosis

746.1

 

Ebstein’s anomaly

746.2

 

Aortic valve stenosis

746.3

 

Hypoplastic left heart syndrome

746.7

 

Patent ductus arteriosus >2500 gms

747.0

 

Coarctation of aorta

747.10

 

Pulmonary artery anomalies

747.3

Congenital anomalies of the Respiratory System

 

 

 

Anomalies of larynx/trachea/bronchus

748.30

 

Lung agenesis/hypoplasia

748.5

 

Other respiratory anomalies

 

Congenital Anomalies of the Orofacial Area

 

 

 

Cleft palate without cleft lip

749.00 -749.04

 

Cleft lip with or without cleft palate

749.1,749.2

 

Choanal atresia

748.0

Congenital Anomalies of the Gastrointestinal Tract

 

 

 

Esophageal atresia/tracheoesophageal fistula

750.3

 

Atresia/stenosis of intestine and rectum

751.10,751.2

 

Hirschsprung’s disease (congenital megacolon)

751.3

 

Anomalies of internal fixation of bowel

751.40

 

Biliary atresia

751.61

 

Malrotation of intestine

751.4*

 

Pyloric stenosis

750.5

 

Anorectal malformation

751.4*

Congenital Anomalies of the Genitourinary System

 

 

 

Renal Agenesis/hypoplasia

753.0

 

Bladder exstrophy

753.5

 

Cloacal exstrophy

*

 

Cystic/dysplastic kidneys

753.10,753.15

 

Obstructive genitourinary defect

753.2,753.6

 

Hypospadias and Epispadias

752.6

 

Ambiguous genitalia

752.9*

 

Polycystic kidneys

753.12 -753.14

Congenital Anomalies of the Musculoskeletal Regions

 

 

 

Reduction defect, upper limbs

755.20 -755.29

 

Polydactyly/

Syndactyly/

Adactyly

755.00 -755.02

755.10 -755.14

755.4*

 

Reduction defect, lower limbs

755.30-755.39

 

Arthrogryposis multiplex congenital

754.89*

 

Achondroplasia

756.4

 

Osteogenesis imperfecta

756.51

 

Other skeletal dysplasia Gastroschisis

756.7

 

Omphalocele

756.7

 

Diaphragmatic hernia (moved up)

756.6

 

Scoliosis/Lordosis/Kyphosis

754.0, 756.19

 

Congenital hip dysplasia

754.30, 754.31

 

 

754.35*

 

Club Foot

754.50, 51, 53, 60, 70, 79

 

Craniosynostosis

756.0*

Chromosomal Disorders

 

 

 

Trisomy 21 (Down syndrome)

758.0

 

Trisomy 13

758.1

 

Trisomy 18

758.2

 

Autosomal deletion syndromes

758.30

 

Other conditions due to autosomal anomalies

758.50

 

Gonadal dysgenesis (Turner’s syndrome)

758.60

 

Klinefelter’s syndrome

758.70

 

Other conditions due to sex chromosome anomalies

758.80

 

Conditions due to anomaly of unspecified Chromosome

758.90

 

Fragile X Syndrome

759.83

Other Congenital Malformations

 

 

 

Amniotic bank disruption complex

no code

Embryopathy from Toxic Exposure in Utero

 

 

 

Fetal Alcohol syndrome

760.71

 

Phenytoin

760.79*

 

Isotretinoin

760.79*

 

Warfarin

760.79*

 

 

 

 

Other toxic exposures

760.7x

Conductive hearing loss, external ear

 

389.01

Conductive hearing loss, middle ear

 

389.03

Ear disorder, unspecified

 

388.9

Hearing loss, noise-induced

 

388.12

Hearing loss, sudden, unspecified

 

388.2

Hearing loss, unspecified

 

388.9

Sensorineural hearing loss, unspecified

 

389.10

 

Last Updated: November 07 2014 16:14:59.
site map   |   about this site   |    contact us   |    translate   |    delaware.gov